DSGN logo

DSGN
Design Therapeutics Inc

407
Mkt Cap
$986.2M
Volume
1M
52W High
$17.25
52W Low
$3.11
PE Ratio
-11.40
DSGN Fundamentals
Price
$13.60
Prev Close
$15.79
Open
$15.76
50D MA
$11.38
Beta
1.65
Avg. Volume
282,414.55
EPS (Annual)
-$1.22
P/B
3.89
Rev/Employee
$0.00
$319.45
Loading...
Loading...
News
all
press releases
Design Therapeutics (NASDAQ:DSGN) Stock Price Down 13.5% - Should You Sell?
Design Therapeutics (NASDAQ:DSGN) Stock Price Down 13.5% - What's Next...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Reaches New 1-Year High Following Earnings Beat
Design Therapeutics (NASDAQ:DSGN) Sets New 1-Year High Following Earnings Beat...
MarketBeat·2d ago
News Placeholder
Design Therapeutics Q1 Earnings Call Highlights
Design Therapeutics (NASDAQ:DSGN) outlined its strategy and trial design for DT-216 in Friedreich's ataxia (FA), emphasizing that its ongoing RESTORE-FA multiple ascending dose study is intended to determine whether the therapy can meaningfully increase endogenous frataxin levels and help define a p...
MarketBeat·2d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Posts Earnings Results, Beats Expectations By $0.07 EPS
Design Therapeutics (NASDAQ:DSGN - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, topping the consensus estimate of ($0.36) by...
MarketBeat·2d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sets New 52-Week High - Still a Buy?
Design Therapeutics (NASDAQ:DSGN) Sets New 1-Year High - What's Next...
MarketBeat·9d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - Should You Buy?
Design Therapeutics (NASDAQ:DSGN) Hits New 52-Week High - Should You Buy...
MarketBeat·16d ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Given Consensus Rating of "Moderate Buy" by Analysts
Shares of Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six analysts that are currently covering the stock, Marketbeat.com...
MarketBeat·23d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Hits New 1-Year High - What's Next?
Design Therapeutics (NASDAQ:DSGN) Hits New 12-Month High - Here's What Happened...
MarketBeat·23d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Trading Up 6.8% - Still a Buy?
Design Therapeutics (NASDAQ:DSGN) Stock Price Up 6.8% - Should You Buy...
MarketBeat·24d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - Here's What Happened
Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - What's Next...
MarketBeat·28d ago
<
1
2
...
>

Latest DSGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.